Search research articles
Contact Us
Filters
Showing results (1621-1630 of 1,873) with videos related to
Page
of 188
Sort By:
Journal of the American College of Cardiology
|
May 27, 2026
Exploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders - The EXCALIBUR study
Adam Ioannou, Rishi Patel, Josephine Mansell, et al.
Cardiovascular Drugs and Therapy
|
July 24, 2017
Navigating the Future of Cardiovascular Drug Development-Leveraging Novel Approaches to Drive Innovation and Drug Discovery: Summary of Findings from the Novel Cardiovascular Therapeutics Conference
Thomas J Povsic, Rob Scott, Kenneth W Mahaffey, et al.
European Journal of Heart Failure
|
June 16, 2020
Efficacy and safety of sodium-glucose co-transporter 2 inhibition according to left ventricular ejection fraction in DAPA-HF
Pooja Dewan, Scott D Solomon, Pardeep S Jhund, et al.
Annals of Internal Medicine
|
April 25, 2022
Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction : A Post Hoc Analysis of the DAPA-HF Trial
Jawad H Butt, Pooja Dewan, Béla Merkely, et al.
JAMA Cardiology
|
March 31, 2021
Efficacy and Safety of Dapagliflozin in Men and Women With Heart Failure With Reduced Ejection Fraction: A Prespecified Analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure Trial
Jawad H Butt, Kieran F Docherty, Mark C Petrie, et al.
Circulation
|
April 9, 2021
Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction: An Analysis of DAPA-HF
Pardeep S Jhund, Piotr Ponikowski, Kieran F Docherty, et al.
Circulation
|
November 19, 2019
Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial
Mikhail N Kosiborod, Pardeep S Jhund, Kieran F Docherty, et al.
American Heart Journal
|
August 1, 2025
A pragmatic individually randomized trial to evaluate the effectiveness of high-dose vs standard-dose influenza vaccine in older adults: Rationale and design of the DANFLU-2 trial
Niklas Dyrby Johansen, Daniel Modin, Matthew M Loiacono, et al.
JACC. Heart Failure
|
April 4, 2020
Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction
Jonathan W Cunningham, Muthiah Vaduganathan, Brian L Claggett, et al.
Molecular Psychiatry
|
June 20, 2012
Pooling/bootstrap-based GWAS (pbGWAS) identifies new loci modifying the age of onset in PSEN1 p.Glu280Ala Alzheimer's disease
J I Vélez, S C Chandrasekharappa, E Henao, et al.
Page
of 188
Search research articles
Search
Showing results (1621-1630 of 1,873) with videos related to
Sort By:
Page
of 188
Journal of the American College of Cardiology
|
May 27, 2026
Exploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders - The EXCALIBUR study
Adam Ioannou, Rishi Patel, Josephine Mansell, et al.
Cardiovascular Drugs and Therapy
|
July 24, 2017
Navigating the Future of Cardiovascular Drug Development-Leveraging Novel Approaches to Drive Innovation and Drug Discovery: Summary of Findings from the Novel Cardiovascular Therapeutics Conference
Thomas J Povsic, Rob Scott, Kenneth W Mahaffey, et al.
European Journal of Heart Failure
|
June 16, 2020
Efficacy and safety of sodium-glucose co-transporter 2 inhibition according to left ventricular ejection fraction in DAPA-HF
Pooja Dewan, Scott D Solomon, Pardeep S Jhund, et al.
Annals of Internal Medicine
|
April 25, 2022
Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction : A Post Hoc Analysis of the DAPA-HF Trial
Jawad H Butt, Pooja Dewan, Béla Merkely, et al.
JAMA Cardiology
|
March 31, 2021
Efficacy and Safety of Dapagliflozin in Men and Women With Heart Failure With Reduced Ejection Fraction: A Prespecified Analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure Trial
Jawad H Butt, Kieran F Docherty, Mark C Petrie, et al.
Circulation
|
April 9, 2021
Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction: An Analysis of DAPA-HF
Pardeep S Jhund, Piotr Ponikowski, Kieran F Docherty, et al.
Circulation
|
November 19, 2019
Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial
Mikhail N Kosiborod, Pardeep S Jhund, Kieran F Docherty, et al.
American Heart Journal
|
August 1, 2025
A pragmatic individually randomized trial to evaluate the effectiveness of high-dose vs standard-dose influenza vaccine in older adults: Rationale and design of the DANFLU-2 trial
Niklas Dyrby Johansen, Daniel Modin, Matthew M Loiacono, et al.
JACC. Heart Failure
|
April 4, 2020
Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction
Jonathan W Cunningham, Muthiah Vaduganathan, Brian L Claggett, et al.
Molecular Psychiatry
|
June 20, 2012
Pooling/bootstrap-based GWAS (pbGWAS) identifies new loci modifying the age of onset in PSEN1 p.Glu280Ala Alzheimer's disease
J I Vélez, S C Chandrasekharappa, E Henao, et al.
Page
of 188